08:55 AM EDT, 09/02/2025 (MT Newswires) -- Solventum ( SOLV ) said Tuesday it completed the sale of its purification and filtration business to Thermo Fisher Scientific ( TMO ) for $4 billion, before customary adjustments.

The company said it plans to use the net proceeds from the sale primarily to pay down outstanding debt.

Solventum ( SOLV ) said it also updated its full-year 2025 adjusted EPS guidance to a range of $5.88 to $6.03 from the previous range of $5.80 to $5.95 to reflect the partial year accretion of the accelerated divestiture.